NextCure

IPO

NextCure, Inc.

Public · BELTSVILLE, United States · Founded 2015 · $160.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$160.0M
Last Round
$93.0M Series BNov 2018
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

NextCure is a clinical-stage biopharmaceutical company developing novel immunomedicines to treat cancer and immune-related diseases. Founded in 2015, the company leverages its FIND-IO technology platform to discover and develop first-in-class medicines targeting immune pathways. Headquartered in Beltsville, Maryland, NextCure trades on Nasdaq under the ticker NXTC.

Summary

NextCure is a Biotech company based in BELTSVILLE, United States, founded in 2015. It has raised $160.0M in total across 2 rounds, most recently a $93.0M Series B round in Nov 2018. Investors include Canaan Partners, Hillhouse Capital and Lilly Asia Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMay 2019
$86.3M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NextCure on Indexed.vc
<a href="https://indexed.vc/companies/nextcure"><img src="https://indexed.vc/api/badge/company/nextcure" alt="NextCure on Indexed.vc" width="260" height="76" /></a>